Vanguard Group Inc Kiora Pharmaceuticals Inc Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.12 - $64.44 $8,065 - $4.33 Million
-67,212 Closed
0 $0
Q2 2022

Aug 12, 2022
SELL
$0.36 - $0.68 $3,527 - $6,662
-9,798 Reduced 12.72%
67,212 $31,000
Q1 2022

May 13, 2022
SELL
$0.54 - $1.27 $40,333 - $94,858
-74,692 Reduced 49.24%
77,010 $48,000
Q4 2021

Feb 14, 2022
BUY
$0.86 - $2.11 $130,463 - $320,091
151,702 New
151,702 $229,000

About KIORA PHARMACEUTICALS INC

KPRX Quotes by TradingView
  • Ticker KPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 919,078
  • Market Cap $3.43M
  • Description
  • Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...
More about KPRX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email